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Abstract
Background: Different species and strains of probiotic bacteria confer distinct immunological responses on
immune cells. Lactobacillus rhamnosus GR-1 (GR-1) is a probiotic bacterial strain found in both the intestinal and
urogenital tracts, and has immunomodulatory effects on several cell types including macrophages. However,
detailed immunological responses and the signaling mechanism involved in the response are largely unknown.
Results: We examined the production of GR-1-induced cytokines/chemokines and signaling events in macrophages.
Among 84 cytokines and chemokines examined, GR-1 discretely induced granulocyte colony-stimulating factor (G-CSF)
mRNA at highest levels (>60-fold) without inducing other cytokines such as IL-1α, IL-1β, IL-6 and TNF-α
(<5-fold). The toll-like receptor (TLR) 2/6-agonist PAM2CSK4, TLR2/1-agonist PAM3CSK4 and TLR4-agonist
lipopolysaccharide induced all of these inflammatory cytokines at high levels (>50-fold). The TLR2 ligand
lipoteichoic acid activated all mitogen-activated kinases, Akt and NF-κB; whereas, GR-1 selectively activated
extracellular regulated kinases and p38, NF-κB and Akt, but not c-Jun N-terminal kinases (JNKs) in a TLR2-dependent
manner. Using specific inhibitors, we demonstrated that lack of JNKs activation by GR-1 caused inefficient production
of pro-inflammatory cytokines but not G-CSF production. A secreted heat-labile protein-like molecule, 30–100 kDa in
size, induced the preferential production of G-CSF.
Conclusion: This study elucidated unique signaling events triggered by GR-1, resulting in selective production of the
immunomodulatory cytokine G-CSF in macrophages.
Keywords: Lactobacillus rhamnosus GR-1, G-CSF, Macrophage, TLR2, NF-κB, ERKs, Akt
Background
Microorganisms induce diverse immune responses, which
can be harmful or beneficial to the host. Unlike patho-
genic microbes, probiotics are microorganisms usually iso-
lated from fermented food or healthy individuals, and
confer a health benefit to the host when administered in
adequate amounts [1, 2]. Among various probiotic bac-
teria, Lactobacillus, a Gram-positive facultative anaerobic
bacterium, is a common constituent of the indigenous
microbiota in the human intestinal and urogenital tracts
[3, 4], and have been used as probiotics for preventing or
treating infectious and inflammatory diseases [5, 6]. How-
ever, different Lactobacillus species and strains elicit strik-
ingly different immune responses in a variety of immune
cells and experimental systems [7–10]. L. rhamnosus GG
(LGG) is a well-studied strain that can induce inflamma-
tory responses in dendritic cells (DCs) and aggravate dex-
tran sulfate sodium-induced acute colitis in mice [11, 12].
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In contrast, LGG was shown to have anti-inflammatory ef-
fects on mouse and human macrophage cell lines [7, 13],
and renders beneficial effects on chronic dextran sulfate
sodium-induced mouse colitis and pouchitis in human
[14, 15]. Two soluble factors from LGG, referred to as p75
and p40, prevent apoptotic cell death of intestinal epithe-
lial cells, through activating the epithelial growth factor re-
ceptor [16, 17]. These factors ameliorate dextran sulfate
sodium-induced acute colitis, as well as oxazolone and tri-
nitrobenzenesulfonic acid-induced chronic colitis in mice
[18]. GR-1, which is closely related to LGG, colonizes both
the intestinal and urogenital tracts after oral supplements
[19–21]. In human placental trophoblast cells, GR-1 in-
creases IL-10 and G-CSF production, but suppresses
TNF-α production [22, 23]. In the human bladder carcin-
oma cell line T24, GR-1 alone has little stimulatory effects
in producing inflammatory cytokines and chemokines;
however, potentiated E. coli-induced activation of the nu-
clear factor kappa-light-chain-enhancer of activated B cells
(NF-κB) and production of inflammatory cytokines [24,
25]. GR-1 can also render anti-inflammatory effects on
macrophages [26, 27] and dendritic cells [28], and pro-
motes the generation of regulatory T cells in humans [29].
To date, detailed immune responses and signaling mecha-
nisms elicited by GR-1 remain largely unknown.
Macrophages are key innate immune cells, orchestrat-
ing immune responses through releasing various pro-
and anti-inflammatory cytokines. These cells are highly
populated in the intestinal and urogenital tracts, inter-
acting directly with microorganisms that have crossed
the epithelial barrier [30, 31]. Macrophages detect
microbe-associated molecular patterns (MAMPs) thor-
ough pattern recognition receptors (PRRs) such as toll-like
receptors (TLRs) and nucleotide-binding oligomerization
domain (NOD)-like receptors. Although probiotics harbor
MAMPs, they rarely cause infections and inflammatory
diseases, but discretely modulate host immune responses
through inducing distinct production profiles of cytokines
and chemokines [7–10, 32]. Although details remain to be
elucidated, several strains of probiotic bacteria have been
shown to have immunomodulatory activities through se-
lectively activating PRRs or regulating signaling cascades
initiated by PRRs. For example, cell wall components such
as peptidoglycan [33] and lipoteichoic acid (LTA) [34–36],
cell wall associated polysaccharide [37], S layer protein A
[38], bacteriocins [39, 40], pilus [41] and histamine [42, 43]
have each been shown to modulate pro-inflammatory re-
sponses in macrophages and dendritic cells through acti-
vating specific or unidentified receptors. Also, several
probiotic bacteria were shown to suppress inflammatory
cytokine expression or promote anti-inflammatory cyto-
kines by inhibiting activation of NF-κB [35, 44, 45], JNKs
[46] and extracellular regulated protein kinases (ERKs)
[35, 45]. The present study examined cytokines produced,
signaling cascades activated, and bacterial factor(s) re-
leased by GR-1 in macrophages. We found that a protein-
like factor released by GR-1 specifically and potently in-
duced the immunomodulatory G-CSF through activating




C57BL/6 J wild-type and TLR2−/− (B6.129-Tlr2tmlKir/J)
mice were obtained from The Jackson Laboratory (Bar
Harbor, ME, USA) and were maintained in the animal
care and veterinary facility at the Western University or
University of Montreal, respectively. Nod2−/− mice ob-
tained from Dr. Jean-Pierre Hugot [47] were maintained
in the animal care and veterinary facility at the McGill
University. Male and female mice, aged 4–10 weeks,
were used in all experimental procedures. All experimen-
tal protocols were approved by the Western University
Animal Use Subcommittee, which follows the regulations
of the Animals for Research Act (Ontario) and the
Canadian Council on Animal Care.
Cell cultures, bacteria and reagents
Bone marrow-derived immortalized macrophages from
C57BL/6 J were generated as described previously [48]
and cultured in RPMI 1640 medium (Sigma-Aldrich)
supplemented with 10 % heat-inactivated fetal bovine
serum (Sigma-Aldrich), 1000 U ml-1 penicillin,
10 mg ml-1 streptomycin (Sigma-Aldrich), 5 mM so-
dium pyruvate (Sigma-Aldrich), 5 mM MEM non-
essential amino acids (Sigma-Aldrich) (referred to as
complete RPMI; c-RPMI). Cells were then maintained at
37 °C in a humidified atmosphere with 5 % CO2. L.
rhamnosus GR-1, obtained from Dr. Gregor Reid (The
Canadian Research and Development Centre for Probio-
tics, Lawson Health Research Institute, London, ON,
Canada), was grown anaerobically in De Man, Rogosa
and Sharpe (MRS) agar (Becton Dickinson) using anaer-
obic packs (Becton Dickinson) at 37 °C for 48–72 h. For
cell culture challenge, L. rhamnosus GR-1 were grown
from a single colony in MRS broth (Becton Dickinson)
at 37 °C for 24 h. Uropathogenic E. coli GR-12, originally
isolated from the urine of a patient with pyelonephritis
[49], and Staphylococcus aureus strain Newman were
grown aerobically overnight in Luria-Bertani medium
(Becton Dickinson) and brain-heart infusion broth (Bec-
ton Dickinson), respectively, with agitation at 37 °C. All
bacteria were harvested by centrifugation at 6000 g for
10 min, washed three times with phosphate-buffered sa-
line (PBS) (pH 7.4), and diluted to obtain a final optical
density of 1.0 at 600 nm (representing approximately
109 CFU/ml) in PBS. Lipopolysaccharide (LPS) from E.
coli O111:B4 was from List Biological Laboratories
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(Campbell). PAM2 and PAM3 were purchased from
Invivogen. LTA from S. aureus (indicated otherwise), lip-
ase (from Candida rugosa), Cytochalasin D and RNase
A were obtained from Sigma-Aldrich. DNase was pur-
chased from Roche. LY294002, Akt inhibitor II, NF-κB
activation inhibitor (CAS 545380-34-5), wortmannin,
SB202190, U0126, and JNK inhibitor II were purchased
from Calbiochem (EMD Biosciences). Antibodies for
phospho-p38 (p-p38), p-ERKs, p-SAPK/JNKs, p-Akt, p-
inhibitor κB (IκB) and β-actin were purchased from Cell
Signaling Technology (NEB Biosciences).
Generation of primary bone marrow-derived
macrophages (BMDMs)
Bone marrow cells (BMCs) from wild-type, TLR2−/−,
NOD1−/−, NOD2−/−, and corresponding cross-matched
wild-type mice for each knockout mouse were harvested
from femurs and tibia of mice using a 25.5-gauge needle
and PBS. Isolated cells were cultured in c-RPMI supple-
mented with murine recombinant macrophage (M)-CSF
(20 ng/ml; eBioscience). Cells were then maintained at
37 °C in a humidified atmosphere with 5 % CO2 for
7 days. The culture media were replaced with fresh
media every two days after culture initiation.
Crude LTA purification
Crude LTA was extracted from LGG and S. aureus using
the butanol extraction method as previously described
[50]. Briefly, bacterial cells were sonicated for 15 min,
re-suspended in n-butanol/water (1:1, v/v) and stirred
for 30 min at room temperature. The suspension was
then centrifuged at 8000 g for 30 min, resulting in a
two-phase system. The aqueous phase was lyophilized
to give crude LTA. Subsequently, the lyophilized sam-
ple was re-suspended in PBS and used for further
experiments.
Macrophage cell challenge and cytokine determination
Macrophages were challenged in a 96-well plate format
with 20 colony forming units (CFU/cell) of live bacteria,
unless otherwise indicated, for 4 h in the presence of
antibiotics-free media. Macrophages were then washed
three times and further incubated with c-RPMI to pre-
vent over-growth of bacteria and macrophage cell death.
Macrophages were also treated with cell-free bacterial
spent culture supernatant (SCS; 1/25 dilution), LTA
(10 μg/ml) and LPS (100 ng/ml) in c-RPMI for the time
indicated. Samples for TNF-α and G-CSF enzyme-linked
immunosorbent assays (ELISA) were obtained from cell
culture supernatant after 4 and 24 h challenges, respect-
ively, unless otherwise indicated. Time points for TNF-α
and G-CSF measurements were selected to maximize
preferential production of G-CSF over TNF.
ELISA
To measure the TNF-α and G-CSF levels in cell culture
supernatant, ELISA kits were purchased from eBioscience
(San Diego, CA) and R&D Systems (Minneapolis, MN),
respectively. Standard curves were generated using recom-
binant proteins provided by the manufacturer.
Western blot
Total cell lysate extraction and Western blot analysis
were performed as previously described [26]. Briefly,
total cell lysates were extracted using ice-cold lysis buffer
containing 20 mM MOPS, 15 mM EGTA, 2 mM EDTA,
1 mM Na3VO4, 1 mM DTT, 75 mM β-glycerophosphate,
0.1 mM PMSF, 1 μg/mL aprotinin, 10 μg/mL pepstatin A,
1 μg/mL leupeptin, and 1 % Triton X-100. Following the
incubation of cells with lysis buffer on ice for 5 min, cell
lysates were extracted by centrifuging the homogenate at
18000 g for 15 min. Extracts were then mixed with SDS-
PAGE loading buffer, heated to 100 °C for 5 min, resolved
on 11 % SDS-PAGE polyacrylamide gels (Bio-Rad), and
transferred onto nitrocellulose membranes. Following
that, membranes were blocked with 5 % w/v skim milk for
30 min, immunoblotted with antibodies, and visualized
using an enhanced chemiluminescence detection system
(ECL; Pierce Bioscience). Band intensity quantification
was performed using ImageJ software (National Institutes
of Health, Bethesda, MD).
Cytokines and Chemokines PCR Array
Total RNA was isolated using RNeasy Mini kit (QIAGEN
Canada) according to the manufacture’s recommenda-
tions. Reverse transcription was conducted using the RT2
First Strand Kit (QIAGEN) according to the manufacture’s
protocol. The Q-PCR was performed using the RT2
Profiler PCR Array System Kit for mouse cytokines
and chemokines (QIAGEN) on an Applied Biosystems
StepOnPlus instrument according to the manufacturer
guidelines.
Statistical analysis
Pooled results of several independent experiments were
used in all analyses. Results are reported as mean ± SEM.
Student’s t-test or one-way analysis of variance (ANOVA)
with Tukey’s multiple comparison post hoc test were used
to determine significance at p < 0.05 among experi-
mental groups using Prism 5.0c for Mac OS X
(GraphPad Software, La Jolla, CA).
Results
Production of G-CSF is the most prominent among 84
cytokines and chemokines examined in GR-1-treated
macrophages
We previously showed that GR-1 potently induces G-CSF
but poorly induces TNF-α production in macrophages
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[28]. To further examine production of other cytokines in-
duced by GR-1 and their levels in comparison to other
stimuli, immortalized bone marrow-derived macrophages
(BMDMs) were treated with live GR-1, LPS, PAM2CSK4
and PAM3CSK4 for 5 h, and the expression of 84 cyto-
kines and chemokines were examined using the RT2 Pro-
filer PCR Array System Kit. As shown in Fig. 1 (upper left
panel) and Additional file 1: Table S1, GR-1 potently in-
duced expression of G-CSF mRNAs (>60-fold of those in-
duced in non-treated cells), whereas all others were
induced less than 5-fold. LPS also induced G-CSF mRNA
to ~80-fold; however, it also potently induced other cyto-
kines and chemokines, including CCL5, CCL12, CXCL1,
CXCL3, CXCL9, CXCL10, CXCL11, IL-1α/β, IL-6, IL-12,
TNF-α and TNF superfamily member 10 more than 50-
fold. PAM2CSK4 and PAM3CSK4 also potently induced
G-CSF more than 100-fold; however, they also induced
IL-1α/β, IL-16 and TNF-α more than 50-fold. These re-
sults demonstrate that GR-1 induced a cytokine/chemo-
kine expression profile distinct from those of LPS,
PAM2 and PAM3.
Preferential G-CSF production by GR-1 is unique among
other tested bacteria in primary BMDM
We further examined whether preferential production of
G-CSF was also observed in other bacteria and also in
non-transformed macrophages. BMDMs derived from
C57BL/6j mice were treated with live GR-1, E. coli GR-
12, and S. aureus with 1–200 CFU/cell, and production
of TNF-α (in 4 h) and G-CSF (in 24 h) were measured
using ELISA. Both E. coli and S. aureus induced TNF-α
as low as 1 CFU/cell; whereas, GR-1 did not induce
TNF-α even at 10 CFU/cell (Fig. 2a). GR-1 with higher
than 20 CFU/cell induced TNF-α, but the levels was less
than one-half of those induced by E. coli and S. aureus.
Unlike TNF-α, G-CSF was significantly produced by all
bacteria tested with similar maximal levels (Fig. 2b). GR-
1 induced G-CSF production as low as 10 CFU/cell and
maximally at 50 CFU/cell. S. aureus also gradually in-
duced G-CSF production starting at 1 CFU/cell and
maximally at 20 CFU/cell. E. coli, however, maximally
produced G-CSF even at 1 CFU/cell. Collectively, these
results suggest that E. coli and S. aureus induced both
TNF-α and G-CSF in similar extents; whereas, GR-1
preferentially induced G-CSF over TNF-α. Further
examination on the kinetics of the production of these
cytokines showed that GR-1 induced G-CSF 12 h after
treatment at similar levels induced by LTA (Fig. 2c, right
panel). Unlike G-CSF, production of TNF-α was induced
as early as 4 h of LTA treatment. However, GR-1 did not
induce TNF-α until 12 h post-treatment and the levels
were significantly lower than those by LTA (Fig. 2c, left
panel). Similar results were also obtained in immortal-
ized BMDMs. These results suggest that live GR-1 pref-
erentially produced G-CSF with similar kinetics as LTA

























































































Fig. 1 Production of G-CSF is the most prominent among 84 cytokines and chemokines examined in GR-1-treated macrophages. Immortalized
BMDMs were treated with GR-1 (20 CFU/cell), lipopolysaccharide (LPS; 100 ng/ml), PAM2CSK4 (PAM2; 1 μg/ml) and PAM3CSK4 (PAM3; 1 μg/ml) for
5 h. mRNA expression of various cytokines and chemokines were measured using the RT2 Profiler PCR Array System Kit for mouse cytokines and
chemokines. Data represent average of two independent experiments
Meshkibaf et al. BMC Microbiology  (2015) 15:238 Page 4 of 12
Activation of ERKs, NF-κB and Akt but not JNKs by GR-1
plays a key role in the preferential production of G-CSF
over TNF-α
To examine signaling pathways activated by GR-1, im-
mortalized BMDMs were treated with GR-1 at 20 CFU/
cell for different time points and Western blots against
phosphorylated IκB, Akt, and mitogen-activated protein
kinases (MAPKs; ERKs, p38 and JNKs) were performed.
Consistent with previous studies [51, 52], LTA activated
all MAPKs, Akt and NF-κB signaling cascades after
15–30 min of treatment (Fig. 3a). GR-1 also potently
activated ERKs, but weakly p38, Akt and NF-κB.
However, no activation of JNKs by GR-1 was de-
tected. To further examine which of these signaling
cascades were involved in G-CSF and TNF-α produc-
tion, these cells were pretreated with various inhibi-
tors, and then treated with GR-1 or LTA. As shown
in Fig. 3b, production of G-CSF by GR-1 and LTA
was inhibited by the NF-κB inhibitor (NF-κBi), ERKs
inhibitor (U0126), phosphatidylinositol 3-kinase (PI3K)
inhibitor (wortmanin or LY94002) and Akt inhibitor (Akt
inhibitor II), but not by the p38 inhibitor (SB203580) and
JNKs inhibitor (JNK inhibitor II). Unlike G-CSF, the
production of TNF-α by LTA was inhibited by all the
MAPK inhibitors (U0126, SB203580 & JNK inhibitor II),
but not by the PI3K and Akt inhibitors (wortmanin,
LY94002 and Akt inhibitor II). These results suggest that
activations of ERKs, NF-κB and Akt without activation of
JNKs lead the preferential production of G-CSF over
TNF-α in response to GR-1.
TLR2 plays a key role in inducing G-CSF in GR-1-treated
primary BMDM
GR-1, as a Gram-positive bacterium, harbors several
MAMPs, including lipoproteins/LTA and peptidoglycan,
which activate TLR2 and NOD1/2, respectively. Also
macrophages are professional phagocytes, and activation
of these receptors and subsequent signaling events are
coordinated by phagocytosis [53–55]. Thus, we exam-
ined if phagocytosis was involved in the preferential pro-
duction of G-CSF, using the actin polymerization
inhibitor cytochalasin D (CytD; 5 μg/ml). As shown in
Fig. 4a, CytD pre-treatment inhibited G-CSF production
induced by live GR-1 but not LTA, suggesting that
phagocytosis of GR-1 was necessary for the production
of G-CSF in macrophages. Since TLR2 and NOD1/2 are
main receptors activated by Gram-positive bacteria, we
then examined if these receptors are involved in GR-1-
induced G-CSF production, using BMDM derived from
TLR2-, NOD1- and NOD2-deficinent mice exposed to
GR-1, PAM3CSK4 or LTA. G-CSF production was
normal in NOD1- and NOD2-deficient, but undetectable
in TLR2-deficient BMDMs in response to either GR-1
or PAM3CSK4 (Fig. 4b). NOD1- and NOD2-deficient
BMDMs also produced similar levels of TNF-α as wild-
































Fig. 2 Preferential G-CSF production by GR-1 is unique among other bacteria in primary BMDMs. a-b Primary BMDMs were treated with live S.
aureus, live E. coli GR-12 or live GR-1 at indicated bacteria/macrophage ratios (CFU/cell). Production of TNF-α (a; in 4 h) and G-CSF (b; in 24 h) was
measured from cell culture media using ELISA. [n ≥ 3; p < 0.05 by one-way ANOVA with Tukey’s multiple comparison post hoc test; columns
accompanied by the same letter (a, b or c) are not significantly different from each other]. c Primary BMDMs were treated with live GR-1
(20 CFU/cell) or lipoteichoic acid (LTA; 10 μg/ml) for indicated time points. Production of TNF-α (in 4 h) and G-CSF (in 24 h) was measured from
cell culture media using ELISA. Data shown as mean ± SEM [n ≥ 3]
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BMDMs failed to produce TNF-α by either GR-1 or
PAM3CSK4. Consistent with these results, TLR2-
deficient primary BMDMs did not activate ERKs, p38,
Akt and NF-κB in response to GR-1 (Fig. 4d). GR-1 acti-
vated JNKs in neither wild-type nor TLR2-deficient
BMDMs (data not shown), as in immortalized BMDMs
(Fig. 3a). These data suggest that production of G-CSF
and activation of ERKS, p38, Akt and NF-κB by GR-1
was mediated through TLR2.
A heat-labile protein-like molecule(s) secreted by GR-1
preferentially induces G-CSF production
Since TLR2 activation was required for G-CSF production
by GR-1, we further examined whether crude LTA
prepared from GR-1 induced a similar G-CSF preferential
production effect in immortalized BMDMs. LTA from
GR-1 was ~ 10-fold less effective in inducing both G-CSF
and TNF-α than LTA prepared from S. aureus (Fig. 5a).
However, unlike live GR-1, LTA from GR-1 induced both
TNF-α and G-CSF at similar levels, suggesting that LTA
was not the factor responsible for the preferential produc-
tion of G-CSF. We then examined whether a factor(s) re-
leased from GR-1 had a similar effect on G-CSF
production as in live GR-1. As shown in Fig. 5b, GR-1 cell
free spent culture supernatant (SCS), but not the media
(MRS), preferentially produced G-CSF over TNF-α, and
the production of G-CSF was abolished in SCS treated



















































Fig. 3 Activation of ERKs, NF-κB and Akt but not JNKs by GR-1 plays a key role in the preferential production of G-CSF over TNF-α. a Immortalized
BMDMs were treated with live GR-1 (20 CFU/cell) or lipoteichoic acid (LTA; 10 μg/ml) for 15, 30 and 60 min. Phosphorylation of ERKs, p38, JNKs,
Akt and IκB was analyzed by Western blots, using phospho-specific or β-actin antibodies. Bar graphs demonstrate band intensity quantification
(ratio of protein phosphorylation to β-actin) using the NIH ImageJ program. Data shown as mean ± SEM [n ≥ 3]. b Immortalized BMDMs treated
with GR-1 (20 CFU/cell) or lipoteichoic acid (LTA; 10 μg/ml) in the presence or absence of various inhibitors for NF-κB (NF-κBi; 10 μM), p38 (SB203580;
10 μM), JNKs (JNK inhibitor II; 250 nM), ERKs (U0126; 25 μM), Akt (Akt inhibitor II; 1 μM) and PI3K (wortmannin; 10 μM and PI3K-LY94002; 10 μM). Production
of TNF-α (in 4 h) and G-CSF (in 24 h) was measured from cell culture media using ELISA. Data shown as mean ± SEM (n≥ 3; *, p< 0.05 by Student’s t-test)
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not with lipase, DNase and RNase (Fig. 5b). Treatments of
trypsin or proteinase K had no effects on LPS-induced
TNF-α and G-CSF production, indicating that inhibition
of G-CSF production in GR-1 SCS was not due to residual
effects of these proteases on macrophages. To estimate
the native molecular size(s) of the GR-1 molecule(s), GR-
1-SCS was filtered through different membrane sizes. As
shown in Fig. 5c, the molecule(s) passed through 100 kDa
membranes but not 30 kDa membranes, suggesting that
the GR-1 molecule(s) was between 100 and 30 kDa in na-
tive size. Collectively, these results indicate that the GR-1
factor(s) responsible for preferential G-CSF production in
macrophages is a heat-labile protein-like molecule(s) of
30–100 kDa in native size.
Discussion
Here, we showed that among 84 cytokines/chemokines
examined, GR-1 uniquely and potently induced G-CSF
(Fig. 1 and Additional file 1: Table S1), and the produc-
tion of G-CSF by GR-1 was as efficient as other known
pro-inflammatory stimuli in both kinetics and amounts
(Fig. 2). This observation is consistent with our previ-
ous studies in macrophages [26, 28] and placental
trophoblast cells that showed high levels of G-CSF
production by GR-1 [22, 23]. GR-1 at higher than
20 CFU/cell or after 12 h post-exposure was able to in-
duce TNF-α, albeit at significantly lower levels than
those induced by E. coli GR-12 or S. aureus (Fig. 2).
Since over-growth of GR-1 even after thorough wash
and incubation with antibiotics containing cell culture
media was detected, it is possible that the production
of TNF-α in macrophages treated with GR-1 for 12–
24 h could be due to high numbers of GR-1 (Fig. 2a
and c). Nonetheless, GR-1 induced TNF-α much less
efficiently when compared to other bacteria or LTA,




































































































Fig. 4 TLR2 plays a key role in inducing G-CSF in GR-1-treated BMDM in a phagocytosis dependent manner. a Immortalized BMDM were treated
with the actin polymerase inhibitor cytochalasin D (CytD) for 1 h and then exposed to live GR-1 (20 CFU/cell) or lipoteichoic acid (LTA; 10 μg/ml).
b Primary BMDMs prepared from wild-type (WT), TLR2−/−, NOD1−/− and NOD2−/− mice were treated with live GR-1 (20 CFU/cell), LTA (10 μg/ml)
or Pam3CSK4 (PAM3; 1 μg/mL). a-b Production of TNF-α (in 4 h) and G-CSF (in 24 h) was measured from spent cell culture media using ELISA.
Data shown as mean ± SEM [n ≥ 3]. c Primary BMDMs from wild-type (WT), TLR2−/−, NOD1−/− and NOD2−/− mice were treated with live GR-1
(20 CFU/cell) for 15, 30 and 60 min. Phosphorylation of MAPKs (ERKs, p38 and JNKs), Akt and I-κB was analyzed by Western blots, using phospho-
or β-actin antibodies. Bar graphs demonstrate band intensity quantification (ratio of protein phosphorylation to β-actin) using the NIH ImageJ
program. Data shown as mean ± SEM [n ≥ 3]
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human bladder cells exposed to live GR-1 or GR-1
SCS [24, 25].
Inefficient production of TNF-α by GR-1 was in part
due to poor stimulatory effects of GR-1 cell wall compo-
nents. LTA prepared from GR-1 was ~10-fold less effi-
cient in inducing TNF-α when compared to LTA
similarly prepared from S. aureus (Fig. 5a). Previous
studies have also shown that LTA purified from several
strains of Lactobacillus, including L. plantarum str.
WCFS1 [34], L. casei str. YIT9029 [35], L. fermentum
YIT0159 [35] and LGG [56] are inefficient in producing
pro-inflammatory cytokines such as TNF-α, IL-1β and
IL-6. It is still unknown why LTAs from several strains
of Lactobacillus are inefficient in inducing pro-
inflammatory cytokines. Interestingly, mutant L. plan-
tarum WCFS1 and LGG that lacks D-alanylated LTA in-
duces more anti-inflammatory but less pro-inflammatory
cytokines in monocytes than wild-type LTA [34], and
rendered protective effects on colitis [12, 34]. However,
in another study, alanylation of LTA had no role in the
production of pro-inflammatory cytokines in LGG-
treated macrophages and peripheral mononuclear cells
[56]. Regardless the levels of alanylation, GR-1 LTA is
not likely involved in the G-CSF preferential effect of
GR-1, as GR-1 LTA at high doses induced both TNF-α
and G-CSF at similar extents (Fig. 5a). Another cell wall
component shown to be involved in immunomodulation
by Lactobacillus is peptidoglycan [33, 57]. NOD1 and 2
are PRRs that recognize the peptidoglycan fragments γ-
D-glutamyl-mesodiaminopimelic acid and muramyl di-
peptides, respectively [58, 59]. However, GR-1 potently
and preferentially induced G-CSF in macrophages defi-
cient in either NOD1 or NOD2 (Fig. 4b), suggesting that
GR-1 peptidoglycan is not involved in G-CSF preferen-
tial production by GR-1.
At this moment, the identity of GR-1 factor(s) respon-
sible for the preferential production of G-CSF is elusive.
This study suggested that a protein-like factor, which is
sensitive to heat and proteases, such as trypsin and pro-
teinase K, with a native molecular weight between 30
and 100 kDa, is responsible for G-CSF preferential pro-
duction by GR-1 (Fig. 5b-c). To date, probiotic proteins
known to preferentially induce anti-inflammatory cyto-
kines include surface layer proteins from L. reuteri, L.
casei, [60] and L. acidophilus NCFM [38], and bacterio-
cins released from L. plantarum strains [40, 61]. Immuno-
modulation elicited by surface layer proteins likely acts
through DC-SIGN (DC-specific ICAM3-grabbing non-
integrin) [60, 62], which is distinct from the GR-1 factor(s)
that required TLR2 (Fig. 4a). Secreted factors of L. rhamno-
sus CNCM I-4036 and Bifidobacterium breve CNCM I-
4035 were shown to be more potent than live bacteria
counterpart in suppressing production of pro-inflammatory
cytokines induced by E. coli or Salmonella typhi, respect-
ively, in DCs [63, 64]. However, the identities of these






























Fig. 5 A heat-labile protein-like molecule(s) secreted by GR-1 preferentially induces G-CSF production. a Immortalized BMDMs were treated with
indicated concentrations of GR-1- or S. aureus-n-butanol-extracted crude LTA. Production of TNF-α (in 4 h) and G-CSF (in 24 h) was measured
from spent cell culture media using ELISA. Data shown as mean ± SEM (n≥ 3; *, p < 0.05 by Student’s t-test). b Immortalized BMDMs were treated
with GR-1-cell free spent culture supernatant (SCS; 1/25 dilution) or MRS culture media (1/25 dilution) which had been treated with proteinase K
(200 μg/mL), lipase (200 μg/mL), trypsin (200 μg/mL), DNase (200 μg/mL), RNase (200 μg/mL), and heat (95o C for 3 h). Production of TNF-α
(in 4 h) and G-CSF (in 24 h) was measured from spent cell culture media using ELISA. Data shown as mean ± SEM (n ≥ 3; *, p < 0.05 by Student’s
t-test). c Immortalized BMDMs were treated with MRS culture media (1/25 dilution), GR-1-SCS (1/25 dilution) or GR-1-SCS which had been fractioned
using Centricon centrifugal filter devices with a 100 or 30 kDa molecular weight cutoffs. Production of TNF-α (in 4 h) and G-CSF (in 24 h) was measured
from spent cell culture media using ELISA. Data shown as mean ± SEM [n≥ 3]
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including L. rhamnosus, release bacteriocins which can
directly modulate immune responses [61, 65, 66]. There-
fore, bacteriocin-related proteins released by GR-1 may
have been involved in the G-CSF production. Further
studies on the possible involvement of bacteriocin-related
proteins in G-CSF production are warranted.
GR-1 was shown to release factors that have immuno-
modulatory effects on non-immune cells. GR-1 SCS sig-
nificantly induced G-CSF and macrophage inflammatory
protein 1α/β, but suppressed various LPS-induced pro-
inflammatory cytokines including TNF-α in human de-
cidual cells [67] and in CD-1 pregnant mice [68]. How-
ever, in urinary bladder cells, GR-1 SCS enhanced
activation of NF-κB [24] and production of TNF-α, but
not IL-6 and IL-8, induced by E. coli [25]. In these stud-
ies, GR-1 or GR-1 SCS alone induced NF-κB but little
TNF-α production, which is consistent with our results
(Fig. 3a and 4b). Although it is unknown whether these
responses are mediated by the same factor, molecular
characteristics in a protein-like entity with native mo-
lecular size above 30 kDa appear to be common in both
studies (Fig. 5) [24].
We further examined the signaling pathways required
for G-CSF preferential production in GR-1-treated mac-
rophages. GR-1 activated ERKs, p38, Akt and NF-κB,
but not JNKs, in immortalized and primary BMDM in a
TLR2-dependent manner (Fig. 3a and 4). Based on ex-
periments using specific inhibitors, activation of ERKs,
Akt and NF-κB was involved in G-CSF production,
whereas activation of ERKs, p38, JNKs and NF-κB path-
ways was required for TNF-α production (Fig. 3b).
These results are consistent with previous reports show-
ing that p38 and JNKs are required for production of
pro-inflammatory cytokines, such as TNF-α, IL-1β, IL-6
and IL-8 [69, 70]. Also, p38 and JNKs, but not ERKs, are
involved in the signal transduction of LPS-induced
TNF-α and IL-1β production by Kupffer cells [71] and
RAW 264.7 macrophages [72]. Therefore, lack of JNKs
activation in GR-1-treated macrophages likely contrib-
uted to the inefficient production of pro-inflammatory
cytokines. The PI3K/Akt signaling axis can suppress
TNF-α production through multiple pathways [73], par-
ticularly through inactivating NF-κB but activating cAMP
response-binding protein (CREB), resulting in suppression
of IL-12 and induction of IL-10 production [74]. We
showed that the inhibitors specific for Akt or PI3K inhib-
ited TNF-α, but not G-CSF, production (Fig. 3b). These
results are consistent with previous studies showing that
activation of ERKs, NF-κB and PI3K/Akt pathways are
crucial for G-CSF expression [75, 76]. Recent studies
also showed that activation of PI3K/Akt is required for
TLR-mediated G-CSF production, through inducing ex-
pression of the transcription factor octamer-binding
factor-2 (Oct-2) [77, 78]. Therefore, activation of PI3K/
Akt and ERKs pathways by GR-1 is likely involved in the
preferential production of G-CSF in GR-1-treated
macrophages.
An intriguing fact is that G-CSF production by GR-1
required phagocytosis and TLR2 (Fig. 4a-b). We found
that phagocytosis of GR-1 was required for efficient pro-
duction of G-CSF (Fig. 4a). Recent studies have shown that
TLR2 mediates signaling from endosomal vesicles, in
addition to the plasma membrane, particularly during Bor-
relia burgdorferi infection [79, 80]. Therefore, it is possible
that phagocytosis is required for the activation of endoso-
mal TLR2 by a ligand(s) released or secreted from GR-1.
Further studies are required to unravel whether GR-1
mainly activates endo/phagosomal TLR2. At this moment,
it is also unknown how activation of TLR2 by GR-1 led to
ERKs and p38 activation without JNKs activation, resulting
in G-CSF production without inducing pro-inflammatory
cytokines. However, the anti-inflammatory responses by
activating TLR2 are not restricted in GR-1. Bifidobacter-
ium pseudocatenulatum CECT7765 was recently shown
to produce anti-inflammatory cytokines such as IL-10 and
suppress TNF-α production throughTLR2 [81]. Even puri-
fied LTA or whole cells from lactobacilli were previously
shown to modulate TNF-α expression through a TLR2-
dependent mechanism [34, 35, 82, 83]. Further experi-
ments delineating mechanisms of TLR2 in activating
immunomodulatory responses is of great interest.
The primary function of G-CSF in the generation and
mobilization of neutrophils, G-CSF enhances anti-
microbial function of mature neutrophils [84–86], and
regulates immune responses through suppressing produc-
tion of various pro-inflammatory cytokines in myeloid
cells [26, 27], generating regulatory gut-homing macro-
phages [87], promoting maturation of tolerogenic DCs
[28, 88, 89] and generation of IL-10-secreting CD4+ type
1 T regulatory cells [90]. Therefore, G-CSF production by
GR-1 may play an important role in enhancing anti-
bacterial activities of neutrophils and preventing cell death
of intestinal/urogenital epithelial cells induced by various
stresses, without inducing inflammatory responses. Benefi-
cial effects of probiotics are not limited in the intestine.
Interestingly, a recent study showed that administration of
L. plantarum 299v or GR-1 protected cardiac failure and
hypertrophy in the rat heart [91, 92]. Since G-CSF also
renders cytoprotective effects against various stresses in
neuronal and cardiac cells [93–95], we are tempted to
speculate that G-CSF may also contribute to the cardio-
protective effects of L. plantarum 299v or GR-1.
Conclusion
In summary, this study demonstrated that a protein-like
factor(s) from GR-1 preferentially and potently produced
G-CSF in macrophages through selectively activating
ERKs, NF-κB and Akt in a TLR2-dependent manner.
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